Medication Management Capacity and Independent Living

Medication management capacity describes whether a person has the abilities needed to organize and carry out the tasks involved in using a medicine regimen. These tasks can include identifying a medicine, opening its packaging, understanding the instructions, selecting the intended dose, taking it at the intended time, and maintaining an ongoing supply. [3] [4] Because medication management is one of the instrumental activities of daily living, it connects health care with the practical demands of living independently. [1]

Who This Is Useful For

This page is useful for readers interpreting studies of functional ageing, cognitive change, medication self-management, ageing in place, or transitions between independent and supported living. It explains what medication-management assessments measure, what they leave unmeasured, and why a result should not be treated as a complete judgment of independence. [3] [12]

Medication Management as an Instrumental Activity

The Lawton-Brody framework placed responsibility for taking medicines within instrumental activities of daily living, alongside tasks such as shopping, food preparation, transport, and financial management. [1] These activities differ from basic self-care because they require several capacities to be coordinated across time and within a household or community setting. [1] [3]

A medicine routine may extend beyond swallowing tablets. Research instruments have assessed the ability to recognize medicines, obtain them from packaging, interpret labels, recall instructions, select a dose, use non-oral dosage forms, and arrange refills. [3] [4] This is why an error in medication management does not identify one underlying impairment: the limiting step may be cognitive, sensory, physical, informational, logistical, or a combination of these. [3] [7]

Components of Medication Management Capacity

Capacity, Performance, and Adherence

Capacity is what a person can demonstrate under specified assessment conditions. Everyday performance is what happens in the person's usual environment, while adherence describes the extent to which medication-taking corresponds with an agreed regimen. These constructs overlap, but they are not interchangeable. [3] A person may demonstrate the component skills in a test yet miss doses in ordinary life because routines, beliefs, cost, access, or changing circumstances affect performance. Conversely, assistance or established habits may support accurate everyday use even when an unfamiliar simulated task is difficult. [3] [12] [13]

Evidence linking performance-based capacity measures with real-world adherence remains limited. A systematic review found that most instruments had some construct-validity evidence, but few had been tested against medication outcomes and validation studies were generally of low to moderate quality. [3] In a small study comparing cognitively healthy older adults with adults who had amnestic mild cognitive impairment, the groups reported similarly high confidence even though their observed performance differed. [5]

Cognitive Contributions

Medication tasks can draw on memory, processing speed, attention, comprehension, and executive functions such as planning and set maintenance. [5] [6] In the small matched study of amnestic mild cognitive impairment, medication-management performance was related to memory and executive measures, while the magnitude of overtaking errors was related to processing speed. [5]

Cognitive tests and medication tasks do not provide identical information. In a retrospective clinical sample of 234 older adults, executive function and performance on the Medication Management Ability Assessment each contributed to classification of whether medication assistance was being received. Their combined classification was better than either measure alone, but it was not perfect. [6] Reviews therefore describe cognitive screening as informative but insufficient on its own for determining medication-management capacity. [3] [12]

Physical, Sensory, and Regimen Demands

The physical design of a regimen can change the capacity it requires. In a population-based study of 604 adults aged 81 and older, inability to open packaging varied by container type and was associated with conditions affecting physical or cognitive function; many participants who could not open at least one container were not receiving help. [9] In a separate study of 335 community-dwelling older women, visual acuity, contrast sensitivity, and stereopsis were associated with performance in implementing a medication regimen. [8]

Dosage form also matters. A person may handle tablets but have difficulty with a blister, eye-drop bottle, inhaler, or liquid measure. Video-based work in hospitalized adults aged 70 and older has shown that self-administration can be evaluated separately across different placebo dosage forms, highlighting information that tablet-only tasks may omit. [10] The broader assessment literature similarly notes that many tools incompletely sample packaging and non-oral administration. [3]

Regimen demand is not represented fully by medicine count. Frequency, timing, formulation, food-related instructions, packaging, and changes to an established routine can make two regimens with the same number of medicines different functional tasks. [7] [13]

How Capacity Is Assessed

Established Assessment Instruments

The Drug Regimen Unassisted Grading Scale uses a person's own medicines and scores four steps: identification, access, dosage, and timing. In its initial cross-sectional study of 59 adults aged 70 and older, scores were associated with cognitive function, self-reported medication capacity, and independent- versus assisted-living residence. [2] The Medication Management Instrument for Deficiencies in the Elderly adds domains covering medication knowledge, taking ability, and procurement; its initial home-based validation involved 50 community-dwelling older adults. [4]

Other instruments use fictitious regimens to test performance under common conditions. The Medication Management Ability Assessment, for example, asks a person to learn and later role-play a multi-medicine schedule. [5] A systematic review identified 14 structured performance-based instruments meeting its inclusion criteria, but differences in content, scoring, validation samples, and reference standards limited comparison. [3] Instrument names and scores are therefore not interchangeable measures of one settled construct. [3]

Relationship With Independent Living

Medication management is relevant to independent living because it is a recurring household task linked directly to the use of health care. [1] In the original DRUGS study, participants living independently scored higher on average than those in assisted living. [2] In a 12-month follow-up of the same highly selected retirement-community cohort, baseline DRUGS scores were associated with residence in assisted living at six months, while change in scores was associated with residence at 12 months. [11]

These findings show an association, not a universal threshold for residential placement. The cohorts were small, and residence is influenced by multiple health, functional, social, financial, and service factors beyond medicine use. [3] [11] Medication management can also be shared: one person may take doses while another organizes packaging, obtains refills, or gives prompts. Reviews describe ability as a continuum from unassisted self-management to complete dependence, with different tasks transferred at different points. [12]

Independent living and unassisted medication management are therefore related but not synonymous. Environmental supports can alter actual performance without changing the person's underlying cognitive or physical capacity, and the same level of capacity may lead to different outcomes under different regimen and support conditions. [12] [13]

Evidence Quality and Interpretation

Confidence is strong that medication management is multidimensional and draws on both cognitive and physical abilities. This conclusion is supported by the content of multiple assessment instruments, associations with cognitive measures, and direct studies of vision, packaging, and dosage-form handling. [3] [5] [8] [9] [10]

Confidence is moderate that poorer medication-management capacity marks broader functional vulnerability at group level. Cross-sectional and small longitudinal studies connect task performance with cognition, received assistance, IADL function, and residential status, but the populations and measures differ. [2] [6] [11]

Confidence is lower when predicting real-world adherence, medication errors, or future living arrangements from one score. Reviews report no accepted gold standard, limited independent validation, small and homogeneous samples, and incomplete outcome-prediction evidence. [3] [12] Studies of adherence in cognitive impairment also vary in their definitions, measurement methods, and included populations. [14]

What This Does Not Mean

• A medication-management error does not by itself establish dementia or identify a single cognitive disorder. [3] [5]
• A normal cognitive screening score does not establish that packaging, vision, dexterity, comprehension, supply, and scheduling demands can all be managed. [3] [8] [9]
• Difficulty with one dosage form does not establish difficulty with every medicine or every step of the regimen. [9] [10]
• Receiving help with medicines does not by itself establish inability to live independently; support can be limited to selected tasks. [12] [13]
• A performance-based capacity score is not a direct measurement of everyday adherence. [3] [5]

Practical Interpretation Examples

• If a person knows the schedule but cannot open one package: the observed limitation may be specific to access and handling rather than knowledge of the regimen. [3] [9]
• If a simulated task is difficult but the usual routine is accurate: familiarity, environmental cues, or shared support may be sustaining everyday performance beyond what the unfamiliar test captures. [3] [12]
• If confidence is high but observed errors occur: self-report and direct performance are providing different information, and neither alone explains the source or real-world frequency of the errors. [5] [12]
• If capacity declines over time: the change may be a marker of broader functional vulnerability, but it does not determine a residential outcome without wider contextual evidence. [11] [13]

Related Reading

• Instrumental Activities of Daily Living in Ageing Research
• Executive Function and Independent Living in Older Adults
• Polypharmacy and Functional Health in Later Life
• Care Dependence and Loss of Independence in Later Life

Summary

Medication management capacity is a higher-order functional construct produced by the interaction of cognitive, physical, sensory, informational, regimen, and environmental demands. [3] [7] Its assessment can reveal specific barriers and add information beyond general cognitive testing or self-report, but capacity in a structured setting is not identical to adherence or daily performance. [3] [5] Medication-management difficulty can mark functional vulnerability, while conclusions about independent living require a broader view of the person's abilities, routine, supports, and environment. [11] [12] [13]

References

1. Lawton, M. P., & Brody, E. M. (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist, 9(3 Part 1), 179-186. https://doi.org/10.1093/geront/9.3_Part_1.179
2. Edelberg, H. K., Shallenberger, E., & Wei, J. Y. (1999). Medication management capacity in highly functioning community-living older adults: detection of early deficits. Journal of the American Geriatrics Society, 47(5), 592-596. https://pubmed.ncbi.nlm.nih.gov/10323653/
3. Elliott, R. A., & Marriott, J. L. (2009). Standardised assessment of patients' capacity to manage medications: a systematic review of published instruments. BMC Geriatrics, 9, 27. https://pmc.ncbi.nlm.nih.gov/articles/PMC2719637/
4. Orwig, D., Brandt, N., & Gruber-Baldini, A. L. (2006). Medication management assessment for older adults in the community. The Gerontologist, 46(5), 661-668. https://pubmed.ncbi.nlm.nih.gov/17050757/
5. Sumida, C. A., Vo, T. T., Van Etten, E. J., & Schmitter-Edgecombe, M. (2019). Medication management performance and associated cognitive correlates in healthy older adults and older adults with amnestic mild cognitive impairment. Archives of Clinical Neuropsychology, 34(3), 290-300. https://pmc.ncbi.nlm.nih.gov/articles/PMC6454840/
6. Hallowell, E. S., Sullivan, K. L., Davis, J. D., et al. (2022). The complementary utility of cognitive testing and the Medication Management Ability Assessment in older adults. Neuropsychology, 36(6), 528-539. https://pubmed.ncbi.nlm.nih.gov/35587411/
7. Patel, T., McDougall, A., Ivo, J., et al. (2021). Development and content validation of an instrument to measure medication self-management in older adults. Pharmacy, 9(2), 78. https://pmc.ncbi.nlm.nih.gov/articles/PMC8167785/
8. Windham, B. G., Griswold, M. E., Fried, L. P., et al. (2005). Impaired vision and the ability to take medications. Journal of the American Geriatrics Society, 53(7), 1179-1190. https://pubmed.ncbi.nlm.nih.gov/16108936/
9. Beckman, A., Bernsten, C., Parker, M. G., Thorslund, M., & Fastbom, J. (2005). The difficulty of opening medicine containers in old age: a population-based study. Pharmacy World & Science, 27(5), 393-398. https://pubmed.ncbi.nlm.nih.gov/16341746/
10. Luegering, A., Langner, R., Wilm, S., et al. (2023). Developing a novel tool to assess the ability to self-administer medication: a systematic evaluation of patients' video recordings in the ABLYMED study. Frontiers in Medicine, 10, 1040528. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1040528/full
11. Edelberg, H. K., Shallenberger, E., Hausdorff, J. M., & Wei, J. Y. (2000). One-year follow-up of medication management capacity in highly functioning older adults. The Journals of Gerontology: Series A, 55(10), M550-M553. https://pubmed.ncbi.nlm.nih.gov/11034226/
12. Elliott, R. A., Goeman, D., Beanland, C., & Koch, S. (2015). Ability of older people with dementia or cognitive impairment to manage medicine regimens: a narrative review. Current Clinical Pharmacology, 10(3), 213-221. https://pmc.ncbi.nlm.nih.gov/articles/PMC5396255/
13. Maidment, I., Lawson, S., Wong, G., et al. (2020). Towards an understanding of the burdens of medication management affecting older people: the MEMORABLE realist synthesis. BMC Geriatrics, 20, 183. https://pmc.ncbi.nlm.nih.gov/articles/PMC7272211/
14. Campbell, N. L., Boustani, M. A., Skopelja, E. N., Gao, S., Unverzagt, F. W., & Murray, M. D. (2012). Medication adherence in older adults with cognitive impairment: a systematic evidence-based review. American Journal of Geriatric Pharmacotherapy, 10(3), 165-177. https://pubmed.ncbi.nlm.nih.gov/22657941/